A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)

NCT03472560 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
61
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the Investigational treatments have been moved to a continuation study (NCT05059522)

Conditions

Interventions

Sponsor

Pfizer